Critical Conversations in Rare & Orphan DiseasesChallenges of Diagnosing and Caring for an Individual with Gaucher Disease
Module 3: Overcoming Diagnostic Challenges in Gaucher Disease
Support for the activities in this curriculum has been made possible through an educational grant from Sanofi Genzyme.
After participating in the activity, learners should be better able to:
- Identify strategies for overcoming challenges to diagnosing Gaucher disease
Release date: 02/28/19
Expiration date: 02/28/20
Estimated time to complete: 0.25 hours
Neal Weinreb, MD, FACP
Regional Coordinator and Chair of the International Collaborative Gaucher Group
University of Miami UHealth Sylvester Cancer Center Coral Springs
Coral Springs, FL
The target audience for this initiative is physicians and other providers, including nurse practitioners and physician assistants, who may encounter patients in their practice with undiagnosed Gaucher Disease.
Accreditation and Credit Designation
In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of Participation
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the post-test, and program evaluation. Your certificate can be printed immediately.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:
Dr. Weinreb has the following relationships to disclose:
- Advisory Board for Scientific Information: Genzyme-Sanofi, Pfizer, Shire HGT
- Grant/Research support: Genzyme ICGG Gaucher Registry – PI (University Research Foundation for Lysosomal Storage Diseases Inc)
- Shire HGT Gaucher Outcome Survey: PI (University of Miami Miller School of Medicine; Dept of Human Genetics)
John JD Juchniewicz, MCIS, CHCP; Paul Miniter, MS; Edward Moylan, RP (reviewer) American Academy of CME, Inc.: No relevant financial relationships with any commercial interests.
This activity may contain discussion of off-label or investigational information. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection
Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection
For any questions, please contact: CEServices@academycme.org
© 2019. This CME-certified activity is held as copyrighted © by American Academy of CME, Inc.. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).